Marc Robillard, Tagworks Pharmaceuticals

Title: to be announced
Session: 16:45


to be announced


Tagworks Pharmaceuticals develops and applies in vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics.

Founded in 2011, Tagworks is a spin-out of Royal Philips Electronics, and originates from Philips' molecular imaging expertise. This talk will cover the bootstrapped start of Tagworks, so without investors, and the path forward.

Powered by Invitado Visitor Management